CORTICOSTEROID AND ANTIHISTAMINE MODIFICATION OF BLEOMYCIN-INDUCED FEVEROKEN MM; LOCH J.1979; PROC. SOC. EXPER. BIOL. MED.; USA; DA. 1979; VOL. 161; NO 4; PP. 594-596; BIBL. 11 REF.Article

COMBINATION CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, VINCRISTINE, AND PREDNISONE IN THE TREATMENT OF REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIAOKEN MM; KAPLAN ME.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 3; PP. 441-447; BIBL. 24 REF.Article

EFFETS OF FEVER AND HYPERTHERMIA ON THYROID FUNCTIONSHAFER RB; OKEN MM; ELSON MK et al.1980; J. NUCL. MED.; ISSN 0022-3123; USA; DA. 1980; VOL. 21; NO 12; PP. 1158-1161; BIBL. 15 REF.Article

HEPATITIS AFTER KONYNE ADMINISTRATION = HEPATITE APRES ADMINISTRATION DE KONYNEOKEN MM; HOOTKIN L; DEJAGER RL et al.1972; AMER. J. DIGEST. DIS.; U.S.A.; DA. 1972; VOL. 17; NO 3; PP. 271-274; BIBL. 6REF.Serial Issue

GYNECOMASTIA WITH NITROSOUREA THERAPY.SCHORER AE; OKEN MM; JOHNSON GJ et al.1978; CANCER TREATM. REP.; U.S.A.; DA. 1978; VOL. 62; NO 4; PP. 574-576; BIBL. 3 REF.Article

CAPPING OF PERIPHERAL BLOOD LYMPHOCYTE C3 RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA: RELATIONSHIP TO CHEMOTHERAPYGORMUS BJ; BASARA ML; OKEN MM et al.1981; INT. J. CANCER; ISSN 0020-7136; CHE; DA. 1981; VOL. 27; NO 2; PP. 151-159; BIBL. 31 REF.Article

CHRONIC LYMPHOCYTIC LEUKEMIA IN ASSOCIATION WITH A SECOND LYMPHOPROLIFERATIVE DISORDER: RESPONSE TO CHEMOTHERAPY IN TWO CASESGORDON LI; HRUSHESKY W; OKEN MM et al.1979; MED. PEDIATR. ONCOL.; USA; DA. 1979; VOL. 7; NO 2; PP. 111-116; BIBL. 18 REF.Article

PHARMACOKINETICS OF BLEOMYCIN AFTER IM ADMINISTRATION IN MANOKEN MM; CROOKE ST; ELSON MK et al.1981; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1981; VOL. 65; NO 5-6; PP. 485-489; BIBL. 11 REF.Article

RANDOMIZED CLINICAL TRIAL COMPARING TWO DOSE REGIMENS OF ICRF-159 IN REFRACTORY MALIGNANT LYMPHOMASO'CONNELL MJ; BEGG CB; SILVERSTEIN MN et al.1980; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1980; VOL. 64; NO 12; PP. 1355-1358; BIBL. 4 REF.Article

COMPARISON OF TWO RADIOIMMUNOASSAYS AND A MICROBIOLOGIC ASSAY FOR BLEOMYCINELSON MK; OKEN MM; SHAFER RB et al.1978; MED. PEDIATR. ONCOL.; USA; DA. 1978; VOL. 5; PP. 213-218; BIBL. 13 REF.Article

DISTINCTIVE CHROMOSOMAL ABNORMALITIES IN HISTOLOGIC SUBTYPES OF NON-HODGKIN'S LYMPHOMAYUNIS JJ; OKEN MM; KAPLAN ME et al.1982; N. ENGL. J. MED.; ISSN 0028-4793; USA; DA. 1982; VOL. 307; NO 20; PP. 1231-1236; BIBL. 24 REF.Article

THE INFLUENCE OF HISTOLOGIC SUBTYPE ON TOXICITY AND RESPONSE TO CHEMOTHERAPY IN NON-HODGKIN'S LYMPHOMA. AN EASTERN COOPERATIVE ONCOLOGY GROUP STUDY UTILIZING THE BCVP REGIMEN = L'INFLUENCE DU SOUS-TYPE HISTOLOGIQUE SUR LA TOXICITE ET LA REPONSE A LA CHIMIOTHERAPIE DANS LE LYMPHOME NON HODGKINIEN. UNE ETUDE DE L'EASTERN COOPERATIVE ONCOLOGY GROUP UTILISANT LE REGIME BCVPOKEN MM; COSTELLO WG; JOHNSON GJ et al.1983; CANCER; ISSN 0008-543X; USA; DA. 1983; VOL. 51; NO 9; PP. 1581-1586; ABS. ENG; BIBL. 22 REF.; GRAPHArticle